SAN JOSE, CALIFORNIA / ACCESS Newswire / November 11, 2025 — VSee Health, Inc. (Nasdaq: VSEE), a leader in secure telemedicine technology, has achieved FedRAMP Moderate authorization, enabling the company to deliver compliant, scalable telehealth solutions to U.S. federal agencies and enterprise partners. In parallel, VSee is introducing robotic integration into intensive care units (ICUs), allowing remote specialists to monitor patients and intervene in real time—marking a major advance in virtual critical care.
“The FedRAMP milestone positions us for major government partnerships while reinforcing our mission to deliver measurable ROI and better outcomes,” said Dr. Imo Aisiku, Co-CEO of VSee Health. “We’re not following the telehealth trend—we’re shaping its future.”
Building on strong revenue growth and a solid balance sheet, VSee continues expanding across enterprise and public health markets. The company recently secured a large county mental health services contract and reported 150% year-over-year growth in enterprise deployments.
With its ICU robotics initiative and FedRAMP authorization, VSee is set to accelerate adoption across hospitals, payers, and federal systems—supporting the U.S. telehealth market projected to reach $52.76 billion in 2025 and grow at a 23.84% CAGR through 2034.
About VSee Health
VSee Health (NASDAQ: VSEE) is a telehealth technology and services provider offering high-acuity virtual care through a scalable, API-driven platform. Its solutions combine secure video, connected device data, and seamless EHR integration to support hospitals, health systems, and employers nationwide. Learn more at vseehealth.com
Contact:
VSee Health
Anne Chang
media@vsee.com
VSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.com
